MM+M – Whither Healthcare and Pharma Twitter in the Musk Era?

April 29, 2022

bottom curve

The biggest news story this week was Elon Musk’s expected takeover of Twitter, and this new article from MM+M explores what it could mean specifically for pharma/healthcare marketers. In the article, our VP, Paid Social Alexandra Gilson explains that a lot of this is still speculation, but that brand safety will continue to be a priority both for us and for Twitter. There’s also, she says, a lot of opportunity for pharma brands to continue to be the trustworthy resource for healthcare information. Check out the article here.